HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low-dose weekly methotrexate used to treat cutaneous Rosai-Dorfman disease.

AuthorsJ J Subash, C Kesty, K R Kesty, M Asgari, J Jorizzo
JournalClinical and experimental dermatology (Clin Exp Dermatol) Vol. 43 Issue 7 Pg. 849-851 (10 2018) ISSN: 1365-2230 [Electronic] England
PMID29869440 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Adrenal Cortex Hormones
  • Antimetabolites, Antineoplastic
  • Methotrexate
Topics
  • Administration, Oral
  • Adrenal Cortex Hormones (therapeutic use)
  • Antimetabolites, Antineoplastic (therapeutic use)
  • Female
  • Histiocytosis, Sinus (drug therapy, pathology, radiotherapy)
  • Humans
  • Injections, Intramuscular
  • Methotrexate (administration & dosage, therapeutic use)
  • Middle Aged
  • Radiotherapy (methods)
  • Rare Diseases
  • Recurrence
  • Skin (pathology)
  • Skin Diseases (drug therapy, pathology)
  • Thigh (pathology)
  • Treatment Failure
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: